AOC Development: Conjugation Site Selection, DAR Control & In Vitro Testing | Full Webinar

Oligonucleotide therapeutics hold great promise, but extrahepatic delivery remains a challenge. Antibody–oligonucleotide conjugates (AOCs) are emerging as a powerful solution – provided you can master conjugation chemistry, DAR control, analytical characterization, and functional assessment. https://www.youtube.com/watch?v=CNr9ZsU2qrk In this recorded webinar, our experts from Medicilon cover: How conjugation chemistry impacts AOC consistency and developability Why DAR control […]
BioTrinity 2026

April 14-15, 2026
Convene, 133 Houndsditch, London EC3A 7BX, United Kingdom
Oligonucleotide Therapeutics: Conjugation Chemistry & In Vitro Activity Assessment

April 8, 2026
8:00-9:00 PM ET (5:00–6:00 PM PT)